The short explanation
No, it is a new name for an old, common condition. MASLD stands for metabolic dysfunction-associated steatotic liver disease. It replaces the older term NAFLD (non-alcoholic fatty liver disease). 'Steatotic' simply means fatty. The new name was introduced by international liver societies to focus on the cause, which is usually metabolic: extra weight around the waist, high blood sugar or diabetes, high blood pressure or abnormal cholesterol, rather than defining it only by the absence of alcohol. The advice is largely the same: gradual weight loss if overweight, regular activity, better control of sugar, blood pressure and cholesterol, and limiting alcohol.
What depends on your situation
The parts of this that change from person to person. Uncertainty is stated, not hidden.
- The new naming also has a category for people who have metabolic risk factors and also drink more than a certain amount, called MetALD. If your doctor used MASLD, it may help to ask how alcohol fits into your own picture.
- You may also see MASH on reports, the new name for NASH, meaning there is inflammation as well as fat.
What this answer cannot determine
The boundary of online education. These need a clinician who can see you.
- The name alone cannot tell how much fat, inflammation or scarring your liver has. That depends on your tests and scans.
Questions for your clinician
Take these with you. You can add any of them to an appointment card.
- Which metabolic factors are driving my fatty liver?
- Is there inflammation or scarring, and do I need a fibroscan?
- How much alcohol, if any, is reasonable for me?
- How often should I be rechecked?
When to seek help
Clinician-approved guidance for this topic. When in doubt, being seen is never the wrong choice.
Book an appointment soon
- See your doctor within a few days if you notice yellow eyes, belly swelling or unusual tiredness.
Raise it at a routine appointment
- Book routine follow-up to track your weight, sugar, cholesterol and liver tests.
Sources
The evidence this explanation is built on.
- NAFLD and NASH National Institute of Diabetes and Digestive and Kidney Diseases (NIH)
- Non-alcoholic fatty liver disease (NAFLD) NHS
- Fatty liver disease MedlinePlus (NIH)
Who wrote and reviewed this
Every AskHim answer names its author. A clinically reviewed answer also names the clinician who signed it off — if no clinician is named below, it has not been clinically reviewed.
- Author
- AskHim Editorial (AI-assisted)
- Clinical reviewer
- Nobody yet No clinician has signed this answer off. That is what the “Editorially reviewed” badge means, and why it does not say “Clinically reviewed”. It was written and checked by AskHim’s editorial team against the sources listed above, and it is queued for a clinician who works in this area.
- Review status
- Editorially reviewed
- Last reviewed
- Last reviewed 11 November 2026
- Version
- 1
Correction history
Substantive changes are listed, not quietly edited away.
No corrections have been made since this answer was first published.
Did this answer your question?
Whatever you choose is filed against this version of the answer, never against you, and it is never shown as a count.
“Explain more simply” asks which part was hard to follow, so the author knows what to rewrite. “My question is different” tells the editorial team this answer missed your point, then lets you ask your own question privately. Nothing about you is sent with either.
Saving, following up and reporting are all private. Nothing you do on this page is visible to other readers or to the doctor who wrote it, unless you ask a question.